AMRX (Amneal) Prakiraan volume dodolan

Tandha merek Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals (AMRX) is valued as a reliable producer of budget biosimilars and generics with stringent quality control. The company's target sales level reflects market revenue expectations, where 10.09 expresses the latest metric level. The integration of its own manufacturing plants with pharmacies strengthens the brand's position, while the launch of complex drugs allows it to effectively displace original manufacturers while maintaining high profitability.

Volume dodolan mangsa ngarep perusahaan: Amneal Pharmaceuticals (AMRX) kanggo 04.07.2022 - 18.11.2026

Ringkesan rincian data analitis Amneal Pharmaceuticals Inc (AMRX)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:AMRX Amneal
Produk merek Amneal Pharmaceuticals, Inc.

This indicator compares the issuer's revenue growth rates with industry averages, identifying revenue stagnation and the hidden accumulation of operating expenses in the absence of market dynamics. Analyzing the company's future sales outlook, it is evident that the minimal environmental investments by Amneal Pharmaceuticals (AMRX) in wastewater treatment merely maintain the status quo, which, amid prolonged price stability, signals a risk of capital freeze.

Perusahaan pesaing

Prakiraan volume dodolan HLN|KVUE (Kenvue Inc) - Pendapatan mangsa ngarep perusahaan|Verona Pharma Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan MENS (Jyong Biotech Ltd)|ligand.com - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan perrigo.com|ALVO (Alvotech SA) - Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Prakiraan volume dodolan|ANIP: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Afrezza (MNKD)|Prakiraan volume dodolan amphastar.com (AMPH)|Prakiraan volume dodolan PCRX (pacira.com)|Pendapatan mangsa ngarep perusahaan SPRY|Theravance Biopharma Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Aquestive Therapeutics AQST|SCPH: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Prakiraan volume dodolan|SXTC (China SXT Pharmaceuticals, Inc.) - Prakiraan volume pendapatan perusahaan|Prakiraan pendapatan perusahaan eupraxiapharma.com (EPRX)|Prakiraan volume pendapatan perusahaan BHST|Prakiraan pendapatan perusahaan eXoZymes EXOZ|Pendapatan mangsa ngarep perusahaan ORMP|ENTX - Prakiraan pendapatan perusahaan|HYFT: Prakiraan pendapatan perusahaan|ABVC BioPharma, Inc (ABVC) - Prakiraan pendapatan perusahaan|Cumberland Pharma - Pendapatan mangsa ngarep perusahaan|QNTM (Quantum BioPharma Corp) - Prakiraan volume dodolan|FibroGen, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan TELO|Dodolan mangsa ngarep perusahaan Rani Therapeutics Holdings, Inc.|Prakiraan pendapatan perusahaan Synergy CHC Corp. SNYR|Prakiraan volume dodolan rallybio.com RLYB|Lexaria Bioscience Corp. - Prakiraan volume dodolan|PULM: Prakiraan pendapatan perusahaan|PTHL (ftzy.com.cn) - Volume dodolan mangsa ngarep perusahaan|APM: Prakiraan volume pendapatan perusahaan|LYRA (Lyra Therapeutics Inc) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan IBO (Impact BioMedical)|Volume dodolan mangsa ngarep perusahaan TNFA (TNF Pharmaceuticals)|Prakiraan volume dodolan cbdMD Corp (YCBD)|Prakiraan volume dodolan PRFX (PainReform)|Dodolan mangsa ngarep perusahaan Auris Medical (CYTO)|LIPO - Prakiraan pendapatan perusahaan|Optinose (OPTN) - Volume dodolan mangsa ngarep perusahaan|Pieris (PIRS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan PROC (Procaps Group S.A.)|Volume dodolan mangsa ngarep perusahaan PTPI|QLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan acelyrin.com (SLRN)|TFFP (TFF Pharma) - Pendapatan mangsa ngarep perusahaan